ALS

Topics

View All Topics

News

Latest News

Columbia Gets $15M Grant to Develop Drugs for Rare Forms of ALS

March 18, 2024

Neil A. Shneider, MD, PhD, Claire Tow Associate Professor of Motor Neuron Disorders, is the principal investigator on the grant that will help develop drugs for an underserved portion of ALS patients.

Topic

Research
Hochul to Propose $25 Million in State Funding for A.L.S. Research

By Claire Fahy

January 15, 2024

Neil A. Shneider, MD, PhD, Claire Tow Associate Professor of Motor Neuron Disorders in Neurology, comments on one of the largest state appropriations for research into the neurodegenerative disease.

Topic

Research
Neurology faculty answer questions about Amyotrophic Lateral Sclerosis (ALS) and Glioblastoma (GBM)

October 10, 2023

Matthew B. Harms, MD and Jinsy Andrews, MD, MSc, associate professors of neurology, explain various aspects of ALS. Laura E. Donovan, MD, assistant professor of neurology, talks about GBM

Topic

Neuro-Oncology
They Carry a Gene for ALS but Aren’t Sick. What Does Medical Research Owe Them?

By Jason Mast

September 21, 2023

Matthew B. Harms, MD, Associate Professor of Neurology, and Neil A. Shneider, MD, PhD, Claire Tow Associate Professor of Motor Neuron Disorders (in Neurology) comment on ALS research

Topic

Research
First Gene Therapy for ALS Approved: What Patients Should Know

May 16, 2023

Neil Shneider, MD, PhD, Claire Tow Associate Professor of Neurology, talks about the new approved tofersen (Qalsody), the first drug developed for patients with a rare form of ALS

Topic

Research
ALS: FDA Considering Approval of Drug Tofersen for Rare Form of Disease

April 11, 2023

Dr. Jinsy Andrews, associate professor of neurology at CUIMC, commented on the newly approved oral drug to treat amyotrophic lateral sclerosis (ALS), a nervous system disease that weakens muscles
FDA Approves First ALS Drug in 5 Years After Pleas From Patients

By Laurie McGinley

September 29, 2022

The Food and Drug Administration on Thursday overcame doubts from agency scientists and approved a fiercely debated drug for ALS
Desperate Patients Want a New ALS Drug. The FDA Is Not Sure It Works

By Laurie McGinley

September 9, 2022

Jinsy Andrews, an associate professor in the Department of Neurology at the Vagelos College of Physicians and Surgeons, speaks about the big difference between Aduhelm and AMX0035.
New Initiative to Develop Personalized Therapies for People with Rare Genetic Forms of ALS

May 10, 2022

A new initiative led by Columbia University and the n-Lorem Foundation will develop personalized therapies for individuals with "nano-rare" genetic forms of ALS and treat them for free, for life.

Topic

Research
Promising ALS Therapy Moves Closer to Clinic

January 24, 2022

An experimental drug first tried at Columbia University Irving Medical Center as a last-ditch effort to help a 25-year-old woman with juvenile ALS is now being tested in ALS patients

ALS

Topics

Top Stories

Actor Eric Dane Diagnosed With ALS

Essay: ALS Has Killed Multiple People in My Family. Now the Disease Is Coming for Me

For Life & Love: No Ordinary Campaign” Documentary Includes Columbia Neurologist Dr. Jinsy Andrews

Columbia Awarded $15 Million to Create Medicines for Ultra-Rare Forms of ALS

Latest News

Columbia Gets $15M Grant to Develop Drugs for Rare Forms of ALS

Hochul to Propose $25 Million in State Funding for A.L.S. Research

Neurology faculty answer questions about Amyotrophic Lateral Sclerosis (ALS) and Glioblastoma (GBM)

They Carry a Gene for ALS but Aren’t Sick. What Does Medical Research Owe Them?

First Gene Therapy for ALS Approved: What Patients Should Know

ALS: FDA Considering Approval of Drug Tofersen for Rare Form of Disease

FDA Approves First ALS Drug in 5 Years After Pleas From Patients

Desperate Patients Want a New ALS Drug. The FDA Is Not Sure It Works

New Initiative to Develop Personalized Therapies for People with Rare Genetic Forms of ALS

Promising ALS Therapy Moves Closer to Clinic

Pages

Columbia University Irving Medical Center

ALS

Topics

Search All News

Top Stories

Latest News

Topic

Topic

Topic

Topic

Topic

Topic

Pages